Changes over time in real-world next-generation sequencing (NGS) test use in patients (pts) with advanced non-small cell lung cancer (aNSCLC).

被引：0
|
作者：
Swaminathan, Akshay [1 ]
Stergiopoulos, Stella [2 ]
Snider, Jeremy [1 ]
Fisher, Virginia [2 ]
Castellanos, Emily [1 ]
Snow, Tamara [1 ]
Cho-Phan, Cheryl [1 ]
Comment, Leah [2 ]
Cunningham, Rachel [2 ]
McCusker, Margaret E. [1 ]
机构：
[1] Flatiron Hlth, New York, NY USA
[2] Fdn Med, Cambridge, MA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
864
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Trends in immunotherapy use in patients with advanced non-small cell lung cancer (aNSCLC) patients: Analysis of real-world data.
    Kushi, Lawrence H.
    Lasiter, Laura
    Belli, Andrew J.
    Boyd, Marley
    Bruinooge, Suanna S.
    Christian, Jennifer
    Garrett-Mayer, Elizabeth
    Hansen, Eric
    Honnold, Rebecca
    Benito, Ruth Pe
    Natanzon, Yanina
    Sakoda, Lori
    Rivera, Donna R. R.
    Rhodes, Whitney
    Robert, Nicholas J.
    Sharon, Elad
    Sweetnam, Connor
    Wagner, Joseph
    Walker, Mark S.
    Allen, Jeff
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Real-world prognostic value of RET fusions in advanced non-small cell lung cancer (aNSCLC)
    Gadgeel, S. M.
    Zhang, Q.
    Lin, H.
    Fajardo, O.
    Trinh, H.
    Arndorfer, S.
    Kong, S.
    Rahman, A.
    Li, S.
    Archer, V. R.
    Gainor, J. F.
    ANNALS OF ONCOLOGY, 2023, 34
  • [23] DOES NEXT GENERATION SEQUENCING (NGS) IMPROVE OUTCOME IN NON-SMALL CELL LUNG CANCER (NSCLC)? A REAL-WORLD DATA (RWD) EXAMPLE
    Gendy, S.
    Kumar, D.
    Maskin, J.
    Obradovic, T.
    Turk, L.
    Viaggi, S.
    VALUE IN HEALTH, 2023, 26 (12) : S28 - S28
  • [24] Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
    Cruz Castellanos, P.
    Rosas Alonso, R.
    Ozaez, I.
    Hernandez, I.
    Losantos, I.
    Gutierrez Sainz, L.
    Higuera Gomez, O.
    Rodriguez Antolin, C.
    Esteban Rodriguez, I.
    Ibanez de Caceres, I.
    de Castro Carpeno, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S558 - S558
  • [25] Real-world survival with first-line (1L) chemotherapy in patients (pts) with advanced non-small cell lung cancer (aNSCLC)
    Waterhouse, D.
    Betts, K. A.
    Zhao, J.
    Rao, S.
    Gupte-Singh, K.
    Rutstein, M.
    Higashi, M. K.
    Schwartzberg, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 29 - U99
  • [26] Real-world treatment patterns before and after receiving PD-L1 test results in patients (pts) with advanced non-small cell lung cancer (aNSCLC)
    Antonia, S. J.
    Wu, N.
    Ge, W.
    Pouliot, J-F.
    Dietz, H.
    Jalbert, J.
    Quek, R. G.
    Harnett, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1419 - S1420
  • [27] A Pathology Group Experience with Targeted Next-Generation Sequencing (NGS) for Non-Small Cell Lung Cancer (NSCLC)
    Xu, D.
    Zhang, M.
    Keenan, S. O.
    Coleman, R.
    Tevis, A. Larson
    Rushford, C.
    Christensen, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1226 - 1226
  • [28] Contemporary management of advanced non-small cell lung cancer aNSCLC) in a large, real-world cohort.
    Presley, Carolyn Jean
    Harrington, Eoghan
    Gippetti, James
    Agarwala, Vineeta
    Bowser, Bryan
    Adelson, Kerin B.
    Herbst, Roy S.
    Abernethy, Amy Pickar
    Gross, Cary Philip
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Treatment patterns in patients with advanced non-small cell lung cancer (aNSCLC): real-world data from the United Kingdom
    Lester, J.
    Khan, S.
    Powell, C.
    Escriu, C.
    Hudson, E.
    Conn, A.
    Mansy, T.
    Chan, S.
    Brock, J.
    Zhuo, X.
    Durand, A.
    Zhang, X.
    Pawar, V.
    LUNG CANCER, 2020, 139 : S47 - S48
  • [30] Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome.
    Pavan, Alberto
    Zulato, Elisabetta
    Calvetti, Lorenzo
    Ferro, Alessandra
    Nardo, Giorgia
    Boscolo, Alice
    Attili, Ilaria
    Frega, Stefano
    Dal Maso, Alessandro
    Pasello, Giulia
    Guarneri, Valentina
    Aprile, Giuseppe
    Conte, Pier Franco
    Indraccolo, Stefano
    Bonanno, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345